A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6290-6296

  Swoboda, Ines ^a   Bugajska Schretter, Agnes ^a   Linhart, Birgit ^a   Verdino, Petra ^b   Keller, Walter ^b   Schulmeister, Ulrike ^a   Sperr, Wolfgang R ^a   Valent, Peter ^a   Peltre, Gabriel ^c   Quirce, Santiago ^d   Douladiris, Nikolaos ^e   Papadopoulos, Nikolaos G ^e   Valenta, Rudolf ^a   Spitzauer, Susanne ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c PSL RESEARCH UNIVERSITY   (France)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PARVALBUMIN;

ALLERGY; ARTICLE; BINDING SITE; CALCIUM BINDING; CIRCULAR DICHROISM; CLINICAL ARTICLE; ESCHERICHIA COLI; FISH; HUMAN; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MUTAGENESIS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; SKIN TEST; WILD TYPE;

EID: 34248201645     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6290     Document Type: Article

References (46)

1. Sicherer, S. H. 2003. Advances in anaphylaxis and hypersensitivity reactions to foods, drugs, and insect venom. J. Allergy Clin. Immunol. 111: 829-834.
2. Brown, S. G. 2004. Clinical features and severity grading of anaphylaxis. J. Allergy Clin. Immunol. 114: 371-376.
3. Kumar, A., S. S. Teuber, and M. E. Gershwin. 2005. Why do people die of anaphylaxis? A clinical review. Clin. Dev. Immunol. 12: 281-287.
4. Sampson, H., L. Mendelson, and J. P. Rosen. 1992. Fatal and near-fatal anaphylactic reaction to food in children and adolescents. N. Engl. J. Med. 327: 380-384.
5. Bock, S. A., A. Munoz-Furlong, and H. Sampson. 2001. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 107: 191-193.
6. Bischoff, S. C., and S. E. Crowe. 2005. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 128: 1089-1113.
7. Bischoff, S. C., A. Herrmann, and M. P. Manns. 1996. Prevalence of adverse reactions to food in patients with gastrointestinal diseases. Allergy 51: 811-818.
8. Etesamifar, M., and B. Wüthrich. 1998. IgE-mediated food allergies including oral allergy syndrome in 383 patients. Allergologie 21: 451-457.
9. Sampson, H. 1999. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103: 717-728.
10. Burks, W. 2002. Current understanding of food allergy. Ann. NY Acad. Sci. 964: 1-12.
11. Aas, K. 1987. Fish allergy and the cod allergen model. In Food Allergy and Intolerance. J. Brostoff and S. T. Challacombe, eds. Balliere Tindall, London. pp. 356-366.
12. Bannon, G. A. 2004. What makes a food protein an allergen? Curr. Allergy Asthma Rep. 4: 43-46.
13. Sicherer, S. H., and H. A. Sampson. 2006. Food allergy. J. Allergy Clin. Immunol. 117: 470-475.
14. Elsayed, S., and K. Aas. 1971. Characterisation of a major allergen (cod): observation on effect of denaturation on the allergenic activity. J. Allergy 47: 283-291.
15. Kretsinger, R. H. 1980. Structure and evolution of calcium-modulated proteins. CRC Crit. Rev. Biochem. 8: 119-174.
16. 2+-binding proteins parvalbumin and oncomodulin. Biochim. Biophys. Acta 1009: 201-215.
17. Heizmann, C. W., and W. Hunziker. 1991. Intracellular calcium-binding proteins: more sites than insights. Trends Biochem. Sci. 16: 98-103.
18. Ikura, M. 1996. Calcium-binding and conformation response in EF-hand proteins. Trends Biochem. Sci. 21: 14-17.
19. Kretsinger, R. H., and C. E. Nockolds. 1973. Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem. 248: 3313-3326.
20. Declercq, J. P., B. Tinant, J. Parello, and J. Rambaud. 1991. Ionic interactions with parvalbumins: crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. J. Mol. Biol. 220: 1017-1039.
21. Permyakov, E. A., V. N. Medvedkin, Y. V. Mitin, and R. H. Kretsinger. 1991. Noncovalent complex between domain AB and domain CD*EF of parvalbumn. Biochim. Biophys. Acta 1076: 67-70.
22. Swoboda, I., A. Bugajska-Schretter, P. Verdino, W. Keller, W. R. Sperr, P. Valent, R. Valenta, and S. Spitzauer. 2002. Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J. Immunol. 168: 4576-4584.
23. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain terminating. Proc. Natl. Acad. Sci. USA 74: 5463-5467.
24. Laemmli, U. K. 1970. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. Bugajska-Schretter, A., M. Grote, L. Vangelista, P. Valent, W. R. Sperr, H. Rumpold, A. Pastore, R. Reichelt, R. Valenta, and S. Spitzauer. 2000. Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin. Gut 46: 661-669.
26. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350-4354.
27. Valent, P., J. Besemer, M. Muhm, O. Majdic, K. Lechner, and P. Bettelheim. 1989. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc. Natl. Acad. Sci. USA 86: 5542-5547.
28. Douladiris, N., I. Swoboda, S. Spitzauer, E. Vassilopoulou, P. Saxoni-Papageorgiou, R. Valenta, and N. Papadopoulos. 2006. Comparison of recombinant major fish allergen Cyp c 1.01 from carp and a hypoallergenic Cyp c 1.01 derivative by skin prick testing in fish allergic Greek children. In Proceedings of the EAACI 2006 Congress, June 10-14. European Academy of Allergology and Immunology, Stockholm, Sweden, p. 22.
29. Vrtala, S., T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, B. Knox, W. R. Sperr, P. Valent, D. Kraft, and R. Valenta. 1998. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 160: 6137-6144.
30. Hochreiter, R., T. Stepanoska, F. Ferreira, R. Valenta, S. Vrtala, J. Thalhammer, and A. Hartl. 2003. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch pollen allergen. Eur. J. Immunol. 33: 1667-1676.
31. 2+ depletion. J. Allergy Clin. Immunol. 101: 67-74.
32. Burks, A. W., D. Shin, G. Cockrell, J. S. Stanley, R. M. Helm, and G. A. Bannon. 1997. Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur. J. Biochem. 245: 334-339.
33. Stanley, J. S., N. King, A. W. Burks, S. K. Huang, H. A. Sampson, G. Cockrell, R. M. Helm, C. M. West, and G. A. Bannon. 1997. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch. Biochem. Biophys. 342: 244-253.
34. Rabjohn, P., E. M. Helm, J. S. Stanley, C. M. West, H. A. Sampson, A. W. Burks, and G. A. Bannon. 1999. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J. Clin. Invest. 103: 535-542.
35. Ayuso, R., G. Reese, S. Leong-Kee, M. Plante, and S. B. Lehrer. 2002. Molecular basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins. Int. Arch. Allergy Immunol. 129: 38-48.
36. s2-casein in cow's milk allergic patients. Int. Arch. Allergy Immunol. 129: 93-96.
37. Jarvinen, K. M., P. Chatchatee, L. Bardina, K. Beyer, and H. A. Sampson. 2001. IgE and IgG binding epitopes on α-lactalbumin and β-lactoglobulin in cow's milk allergy. Int. Arch. Allergy Immunol. 126: 111-118.
38. Niederberger, V., B. Hayek, S. Vrtala, S. Laffer, A. Twardosz, L. Vangelista, W. R. Sperr, P. Valent, H. Rumpold, D. Kraft, et al. 1999. Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7. FASEB J. 13: 843-856.
39. Niederberger, V., F. Horak, S. Vrtala, S. Spitzauer, M. T. Krauth, P. Valent, J. Reisinger, M. Pelzmann, B. Hayek, M. Kronqvist, et al. 2004. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc. Natl. Acad. Sci. USA 101: 14677-14682.
40. Valenta, R. 2002. The future of antigen-specific immunotherapy. Nat. Rev. Immunol. 2: 446-453.
41. Larche, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
42. Cox, L. S., D. L. Linnemann, H. Nolte, D. Weldon, I. Finegold, and H. S. Nelson. 2006. Sublingual immunotherapy: a comprehensive review. J. Allergy Clin. Immunol. 117: 1021-1035.
43. Francis, J. N., and S. R. Durham. 2004. Adjuvants for allergen immunotherapy: experimental results and clinical perspectives. Curr. Opin. Allergy Clin. Immunol. 4: 543-548.
44. Hessel, E. M., M. Chu, J. O. Lizcano, B. Chang, N. Herman, S. A. Kell, M. Wills-Karp, and R. L. Coffman. 2005. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 202: 1563-1573.
45. Spiegelberg, H. L., A. A. Horner, K. Takabayashi, and E. Raz. 2002. Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy. Curr. Opin. Allergy Clin. Immunol. 2: 547-551.
46. Broide, D. H. 2005. DNA vaccines: an evolving approach to the treatment of allergic disorders. Allergy Asthma Proc. 26: 195-198.